Luis Pareras

Degree and PhD in Medicine (UB), specialist in Neurosurgery and Global Executive MBA (IESE).

Founder and Managing Partner of Invivo Partners focused on early-stage investments in the healthcare sector, where he has led the investment strategy and transaction processes.

He serves or has served at the Board of Directors of many life sciences companies including Sanifit (acquired by Vifor), Minoryx, Versantis (acquired by Genfit), Glycardial Diagnostics, n-Life Therapeutics, Peptomyc, Arthex, Pulmobiotics, Gyala, Telum, OneChain Immunotherapeutics, Telomere Therapeutics Corteria and Integra.

Deeply involved in the innovation ecosystem, he is a member and advisor of many healthcare innovation organizations, and author of numerous books in the field of innovation, venture capital and healthcare, including the recently published “Fast-Forward Thinking”.

In the academic space, he teaches at several business schools about healthcare innovation and venture capital.